NEW YORK (GenomeWeb News) – Pharmacogenomics firm Genomas today announced it has obtained clinical laboratory licenses from New York, Florida, and California.

The company's Laboratory of Personalized Health received CLIA certification in 2005, the same year the lab received licensure from Connecticut.

Last year, Genomas was credentialed as a Medicare provider and began providing services in Texas and Pennsylvania.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genomic analysis of Malaysian tuberculosis strain, database of bat genomes, and more.

An editorial appearing at The Scientist bemoans the high numbers of mitochondrial genome papers and suggests a different path for mitochondrial genome research.

Researchers and drug developers are excited about the potential of CRISPR-Cas9-based therapeutics, the Wall Street Journal reports.

US lawmakers want to develop a new incarnation of the National Children's Study, ScienceInsider reports.